A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
Clinical trial NCT05921162 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05921162
- Sponsor
- Nanoscope Therapeutics Inc.
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-14
- Primary completion
- 2025-05-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.